FAM
ARRY

Fortaleza Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Fortaleza Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$74K Buy
+4,405
New +$70.1K 0.6% 84

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fortaleza Asset Management's ARRY Position: Q2 2018 in Review

Fortaleza Asset Management opened a new position in Array Biopharma Inc (ARRY) in Q2 2018: 4,405 shares worth $74K. The stake represents 0.6% of the portfolio and ranks #84 among its holdings.

223 funds tracked by Wall St. Rank hold ARRY as of Q2 2018.

  • Fortaleza Asset Management held 4,405 shares of Array Biopharma Inc worth $74K as of Q2 2018.
  • Array Biopharma Inc was a new Fortaleza Asset Management position in Q2 2018.
  • Array Biopharma Inc made up 0.6% of Fortaleza Asset Management's portfolio in Q2 2018, its #84 holding.
  • 223 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2018.

Based on Fortaleza Asset Management's 13F filing for Q2 2018, filed 17 Jul 2018.